
IT IS increasingly obvious that we are on the cusp of a revolution in artificial intelligence that will be no less profound than the arrival of the printing press or the internet, as we explore in this special issue. Nobody can say for sure exactly what this future will be, but optimists – including many of those working in the companies behind the technologies – foresee one in which AI will allow us to live our best lives (see “How this moment for AI will change society foreverâ€). Not everyone shares that rosy outlook, however, and whether it is existential risk of an AI coup d’état (see “Why do some AI researchers dismiss the potential risks to humanity?â€), continued sexist and racist bias or swingeing job losses caused by automation, the need for legislation has become the issue of the day.
AI presents a larger than usual challenge on this front. The pharmaceutical industry can offer inspiration, but AI is both more complex and more opaque. It is arguably the first of humanity’s creations that nobody fully understands. Is conclusive proof of safety even possible?
Advertisement
It is true that pharmaceutical regulators don’t need to know how a drug works to ensure it is safe to prescribe. But clinical trials are easier than checking that an AI capable of everything from diagnosing cancer to autonomously driving a bus is safe in every possible scenario. And while it takes years to trial a new drug, new AI models are appearing almost weekly.
Tech firms must accept responsibility. The code and data inside today’s AI models – emerging almost exclusively from companies rather than academic institutions – often aren’t being released. This lack of transparency isn’t good enough given the stakes. We need a robust framework to vet AI models and penalise those that fall short of strict ethical rules, but for that to work, tech firms should lead from the front by sharing the information needed to assess the risks. That may not suit their shareholders, but when the risks are so large, money shouldn’t come first.
These systems may be the most complex we have had to regulate, yet as we hear in our feature “How smart is ChatGPT really – and how do we judge intelligence in AIs?â€, none of it is magic. Those creating AIs need to stop acting like it is.